| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |